The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase 1 dose-finding study to evaluate safety and tolerability of CVGBM in patients with newly diagnosed and surgically resected MGMT-unmethylated glioblastoma.
 
Ghazaleh Tabatabai
Consulting or Advisory Role - Advanced Accelerator Applications/Novartis (Inst); Bayer Germany (Inst); Boehringer Ingelheim (Inst); CureVac (Inst)
 
Louisa Von Baumgarten
No Relationships to Disclose
 
Martin J. Van Den Bent
Consulting or Advisory Role - Anheart Therapeutics; AstraZeneca; Boehringer Ingelheim; carthera; chimerix; Fore Biotherapeutics; Genenta Science; Incyte; Mundipharma; Nerviano Medical Sciences; Roche; Servier
Speakers' Bureau - Servier
 
Michael C Burger
No Relationships to Disclose
 
Pierre Freres
Honoraria - Astellas Pharma; Bristol-Myers Squibb; Janssen
Consulting or Advisory Role - Astellas Pharma BV; Merck; Pfizer
Travel, Accommodations, Expenses - Astellas Pharma; Janssen; Merck Sharp & Dohme
 
Martin Glas
Consulting or Advisory Role - Novartis; Novocure; Seagen; SERVIER
Research Funding - Novocure
Patents, Royalties, Other Intellectual Property - Scheffer et al. Peripheral zone tumor cells, methods for their preparation and use erteilt: EP2324111 B1; AU2009291203; US9103819 B2)
Travel, Accommodations, Expenses - Janssen-Cilag; Novocure
 
Peter Hau
No Relationships to Disclose
 
Ulrich Herrlinger
Honoraria - Bayer; Medac
Speakers' Bureau - Bayer; Medac
 
Iris Mildenberger
No Relationships to Disclose
 
Bart Neyns
Consulting or Advisory Role - Bristol-Myers Squibb; Merck Sharp & Dohme; Novartis; Pierre Fabre
Research Funding - Novartis (Inst)
Travel, Accommodations, Expenses - Merck Sharp & Dohme; Pierre Fabre
 
Henning Sebastian Schafer
No Relationships to Disclose
 
Clemens Seidel
Honoraria - Seagen
Consulting or Advisory Role - Seagen
 
Rachel Galot
Travel, Accommodations, Expenses - MSD; MSD
 
Antje Wick
No Relationships to Disclose
 
Martin H. Falk
Employment - CureVac SE
Stock and Other Ownership Interests - CureVac SE
 
Laura Leticia de Freitas Chama
Employment - CureVac SE
 
Peter Kelemen
Employment - CureVac SE
Stock and Other Ownership Interests - CureVac SE
Patents, Royalties, Other Intellectual Property - MorphoSys
 
Sven D Koch
Employment - CureVac SE
Stock and Other Ownership Interests - BioNTech; CureVac SE; Gritstone Bio; Novo Nordisk; Pfizer; Vivoryon
Research Funding - CureVac SE
Travel, Accommodations, Expenses - CureVac SE
 
Paula Romer Roche
Employment - CureVac SE
Stock and Other Ownership Interests - CureVac SE
 
Senta Ulrike Gnad-Vogt
Employment - CureVac SE
Leadership - CureVac SE
Stock and Other Ownership Interests - Bavarian Nordic; BioNTech; Bristol-Myers Squibb; CureVac SE
Honoraria - CureVac SE
Patents, Royalties, Other Intellectual Property - CureVac SE